![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 7, 4140-4146, February 12, 1999
From the Division of Molecular Medicine, Department of Medicine,
Columbia University, New York, New York 10032
Abnormalities of plasma high density lipoprotein
(HDL) levels commonly reflect altered metabolism of the major HDL
apolipoproteins, apoA-I and apoA-II, but the regulation of
apolipoprotein metabolism is poorly understood. Two mouse models of
obesity, ob/ob and db/db, have markedly
increased plasma HDL cholesterol levels. The purpose of this study was
to evaluate mechanisms responsible for increased HDL in
ob/ob mice and to assess potential reversibility by leptin administration. ob/ob mice were found to have increased HDL
cholesterol (2-fold), apoA-I (1.3-fold), and apoA-II (4-fold). ApoA-I
mRNA was markedly decreased (to 25% of wild-type) and apoA-II
mRNA was unchanged, suggesting a defect in HDL catabolism. HDL
apoprotein turnover studies using nondegradable radiolabels confirmed a
decrease in catabolism of apoA-I and apoA-II and a 4-fold decrease in
hepatic uptake in ob/ob mice compared with wild-type, but
similar renal uptake. Low dose leptin treatment markedly lowered HDL
cholesterol and apoA-II levels in both ob/ob mice and in
lean wild-type mice, and it restored apoA-I mRNA to normal levels
in ob/ob mice. These changes occurred without significant
alteration in body weight. Moreover, ob/ob neuropeptide
Y
/
mice, despite marked attenuation of diabetes and
obesity phenotypes, showed no change in HDL cholesterol levels relative
to ob/ob mice. Thus, increased HDL levels in
ob/ob mice reflect a marked hepatic catabolic defect for
apoA-I and apoA-II. In the case of apoA-I, this is offset by decreased
apoA-I mRNA, resulting in apoA-II-rich HDL particles. The studies
reveal a specific HDL particle catabolic pathway that is down-regulated
in ob/ob mice and suggest that HDL apolipoprotein turnover
may be regulated by obesity and/or leptin signaling.
This article has been cited by other articles:
![]() |
R. D. Atkinson, K. R. Coenen, M. R. Plummer, M. L. Gruen, and A. H. Hasty Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E284 - E290. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Coenen and A. H. Hasty Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E492 - E499. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, J. Liao, N. Li, C. Zhou, Q. Liu, G. Wang, R. Zhang, S. Zhang, L. Lin, K. Chen, et al. From the Cover: A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice PNAS, January 16, 2007; 104(3): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Pagler, S. Golsabahi, M. Doringer, S. Rhode, G. J. Schutz, M. Pavelka, C. Wadsack, M. Gauster, A. Lohninger, H. Laggner, et al. A Chinese Hamster Ovarian Cell Line Imports Cholesterol by High Density Lipoprotein Degradation J. Biol. Chem., December 15, 2006; 281(50): 38159 - 38171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shetty, E. R.M. Eckhardt, S. R. Post, and D. R. van der Westhuyzen Phosphatidylinositol-3-Kinase Regulates Scavenger Receptor Class B Type I Subcellular Localization and Selective Lipid Uptake in Hepatocytes Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Goldberg and H. M. Dansky Diabetic Vascular Disease: An Experimental Objective Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1693 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, N. Dedousis, A. Bandi, G. D. Lopaschuk, and R. M. O'Doherty Liver Triglyceride Secretion and Lipid Oxidative Metabolism Are Rapidly Altered by Leptin in Vivo Endocrinology, March 1, 2006; 147(3): 1480 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Wu and D. E. Cohen Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1067 - G1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, L. N. Thorne, N. M. Punjabi, C.-K. Sun, A. R. Schwartz, P. L. Smith, R. L. Marino, A. Rodriguez, W. C. Hubbard, C. P. O'Donnell, et al. Intermittent Hypoxia Induces Hyperlipidemia in Lean Mice Circ. Res., September 30, 2005; 97(7): 698 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gruen, M. R. Plummer, W. Zhang, K. A. Posey, M. Linton, S. Fazio, and A. H. Hasty Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I J. Lipid Res., September 1, 2005; 46(9): 2007 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stephenson, J. Tunstead, A. Tsai, R. Gordon, S. Henderson, and H. M. Dansky Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2027 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lundasen, W. Liao, B. Angelin, and M. Rudling Leptin Induces the Hepatic High Density Lipoprotein Receptor Scavenger Receptor B Type I (SR-BI) but Not Cholesterol 7{alpha}-Hydroxylase (Cyp7a1) in Leptin-deficient (ob/ob) Mice J. Biol. Chem., October 31, 2003; 278(44): 43224 - 43228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hyogo, S. Roy, and D. E. Cohen Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice J. Lipid Res., June 1, 2003; 44(6): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hyogo, S. Roy, B. Paigen, and D. E. Cohen Leptin Promotes Biliary Cholesterol Elimination during Weight Loss in ob/ob Mice by Regulating the Enterohepatic Circulation of Bile Salts J. Biol. Chem., September 6, 2002; 277(37): 34117 - 34124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hofmann, H.-J. Dong, Z. Li, W. Cai, J. Altomonte, S. N. Thung, F. Zeng, E. A. Fisher, and H. Vlassara Improved Insulin Sensitivity Is Associated With Restricted Intake of Dietary Glycoxidation Products in the db/db Mouse Diabetes, July 1, 2002; 51(7): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barazzone-Argiroffo, P. Muzzin, Y. R. Donati, C.-D. Kan, M. L. Aubert, and P.-F. Piguet Hyperoxia increases leptin production: a mechanism mediated through endogenous elevation of corticosterone Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1150 - L1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Ferrante, M. Thearle, T. Liao, and R. L. Leibel Effects of Leptin Deficiency and Short-Term Repletion on Hepatic Gene Expression in Genetically Obese Mice Diabetes, October 1, 2001; 50(10): 2268 - 2278. [Abstract] [Full Text] |
||||
![]() |
S. VanPatten, N. Ranginani, S. Shefer, L. B. Nguyen, L. Rossetti, and D. E. Cohen Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G393 - G404. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsuoka, Y. Ogawa, H. Masuzaki, K. Ebihara, M. Aizawa-Abe, N. Satoh, E. Ishikawa, Y. Fujisawa, A. Kosaki, K. Yamada, et al. Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E334 - E339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Eckardstein, J.-R. Nofer, and G. Assmann High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 13 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tall, X.-c. Jiang, Y. Luo, and D. Silver 1999 George Lyman Duff Memorial Lecture : Lipid Transfer Proteins, HDL Metabolism, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1185 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hammad, S. Stefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer Jr., and W. S. Argraves Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis PNAS, August 31, 1999; 96(18): 10158 - 10163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Hasty, H. Shimano, J.-i. Osuga, I. Namatame, A. Takahashi, N. Yahagi, S. Perrey, Y. Iizuka, Y. Tamura, M. Amemiya-Kudo, et al. Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein Receptor J. Biol. Chem., September 28, 2001; 276(40): 37402 - 37408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Silver, N. Wang, X. Xiao, and A. R. Tall High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion J. Biol. Chem., June 29, 2001; 276(27): 25287 - 25293. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Liang and A. R. Tall Transcriptional Profiling Reveals Global Defects in Energy Metabolism, Lipoprotein, and Bile Acid Synthesis and Transport with Reversal by Leptin Treatment in Ob/ob Mouse Liver J. Biol. Chem., December 21, 2001; 276(52): 49066 - 49076. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Parhami, Y. Tintut, A. Ballard, A. M. Fogelman, and L. L. Demer Leptin Enhances the Calcification of Vascular Cells : Artery Wall as a Target of Leptin Circ. Res., May 11, 2001; 88(9): 954 - 960. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |